uniQure N.V. Inventory, Raw Materials, Net of Reserves
uniQure N.V. (QURE) had Inventory, Raw Materials, Net of Reserves of $6.33 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2025-02-27
- 2024-03-31: Inventory, Raw Materials, Net of Reserves $6.33M.
- 2023-12-31: Inventory, Raw Materials, Net of Reserves $7.16M.
- 2023-09-30: Inventory, Raw Materials, Net of Reserves $7.43M.
- 2023-06-30: Inventory, Raw Materials, Net of Reserves $6.01M.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2024-03-31 | $6.33M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $7.16M 10-K · filed 2025-02-27 |
| 2023-09-30 | $7.43M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $6.01M 10-Q · filed 2023-08-01 |
| 2022-12-31 | $3.58M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.45M 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |